Submitted by Anonymous (not verified) on 9 November 2023 - 10:09
Human medicines European public assessment report (EPAR): Zokinvy, lonafarnib, Progeria;Laminopathies, Date of authorisation: 18/07/2022, Revision: 2, Status: Authorised
Source: